CA1089448A - Process for purifying glucagon - Google Patents

Process for purifying glucagon

Info

Publication number
CA1089448A
CA1089448A CA275,504A CA275504A CA1089448A CA 1089448 A CA1089448 A CA 1089448A CA 275504 A CA275504 A CA 275504A CA 1089448 A CA1089448 A CA 1089448A
Authority
CA
Canada
Prior art keywords
glucagon
percent
column
gel
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA275,504A
Other languages
English (en)
French (fr)
Inventor
John G. Stilz
Richard L. Jackson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of CA1089448A publication Critical patent/CA1089448A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA275,504A 1975-12-17 1977-04-04 Process for purifying glucagon Expired CA1089448A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/641,419 US4033941A (en) 1975-12-17 1975-12-17 Process for purifying glucagon

Publications (1)

Publication Number Publication Date
CA1089448A true CA1089448A (en) 1980-11-11

Family

ID=24572291

Family Applications (1)

Application Number Title Priority Date Filing Date
CA275,504A Expired CA1089448A (en) 1975-12-17 1977-04-04 Process for purifying glucagon

Country Status (7)

Country Link
US (1) US4033941A (enExample)
CA (1) CA1089448A (enExample)
DE (1) DE2721027A1 (enExample)
FR (1) FR2389598B1 (enExample)
GB (1) GB1576344A (enExample)
NL (1) NL7703758A (enExample)
SE (1) SE443512B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4617376A (en) * 1985-07-01 1986-10-14 Eli Lilly And Company Process for recovering glucagon from pancreas glands
CA1284000C (en) * 1985-07-01 1991-05-07 David Gregory Maskalick Process for recovering glucagon from pancreas glands
EP2049149B1 (en) 2006-07-31 2015-04-15 Novo Nordisk A/S Pegylated extended insulins
WO2008034881A1 (en) * 2006-09-22 2008-03-27 Novo Nordisk A/S Protease resistant insulin analogues
EP2502618A3 (en) * 2007-04-30 2012-10-03 Novo Nordisk A/S Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
US20100190706A1 (en) * 2007-06-01 2010-07-29 Novo Nordisk A/S Stable Non-Aqueous Pharmaceutical Compositions
CN101970477B (zh) * 2008-03-14 2014-12-31 诺沃-诺迪斯克有限公司 蛋白酶稳定的胰岛素类似物
EP2910570B1 (en) 2008-03-18 2016-10-12 Novo Nordisk A/S Protease stabilized, acylated insulin analogues
CA2870313A1 (en) 2012-04-11 2013-10-17 Novo Nordisk A/S Insulin formulations
BR112016007166A2 (pt) 2013-10-07 2017-09-12 Novo Nordisk As derivado de um análogo de insulina
RU2758367C2 (ru) 2016-12-16 2021-10-28 Ново Нордиск А/С Фармацевтические композиции, содержащие инсулин
DK3517543T3 (da) 2018-01-30 2020-12-07 Bachem Ag Fremstilling af glucagonpeptider
CN113024658B (zh) * 2019-12-25 2022-10-21 翰宇药业（武汉）有限公司 一种纯化利拉鲁肽的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3715345A (en) * 1970-08-03 1973-02-06 Lilly Co Eli Glucagon separation process
DE2258080C3 (de) * 1972-11-27 1981-12-17 Eli Lilly And Co., Indianapolis, Ind. Verfahren zur Gewinnung von Hexatriacontapeptiden
US3878186A (en) * 1973-05-09 1975-04-15 Lilly Co Eli Process for purifying insulin
US3875138A (en) * 1973-09-27 1975-04-01 Lilly Co Eli Process for recovering glucagon

Also Published As

Publication number Publication date
NL7703758A (nl) 1978-10-09
FR2389598A1 (enExample) 1978-12-01
SE7705162L (sv) 1978-11-04
DE2721027A1 (de) 1978-11-16
FR2389598B1 (enExample) 1981-06-19
SE443512B (sv) 1986-03-03
US4033941A (en) 1977-07-05
GB1576344A (en) 1980-10-08

Similar Documents

Publication Publication Date Title
CA1089448A (en) Process for purifying glucagon
Racker [127] Glutathione reductase1 (liver and yeast)
Arakawa et al. The effects of arginine on protein binding and elution in hydrophobic interaction and ion-exchange chromatography
US5157021A (en) Insulin derivatives and pharmaceutical preparations containing these derivatives
US3876623A (en) Process for purifying insulin
WO1986005497A1 (en) Novel insulin derivatives and pharmaceutical preparations containing these derivatives
NO146698B (no) Fremgangsmaate for fremstilling av et stabilt langtidsvirkende insulinprodukt
Pflumm et al. Optical Activity of Cystine-containing Proteins: III. Circular dichroism spectra of reduced and reoxidized pancreatic ribonuclease
Frieden et al. Studies of the enzyme fumarase. II. 1 Isolation and physical properties of crystalline enzyme
Free et al. Separation and properties of multiple components of bovine growth hormone
CA1253997A (en) Process for purifying growth hormone-like materials
GB2038340A (en) Process for purifying insulin
US4617376A (en) Process for recovering glucagon from pancreas glands
Blasi et al. Thyroidal Phenylpyruvate Tautomerase: ISOLATION AND CHARACTERIZATION
CA1284000C (en) Process for recovering glucagon from pancreas glands
Gill et al. Expression and purification of the cytoplasmic N-terminal domain of the Na/HCO3 cotransporter NBCe1-A: structural insights from a generalized approach
US3875138A (en) Process for recovering glucagon
Epand et al. Carboxyl group modification in glucagon
Ozawa Reaction of insulin with ethyl glycinate and 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide
US3637462A (en) Purification of enzymes
WO1990000177A1 (en) Improved process for purifying insulin
CA1143309A (en) Apoglucose oxidase preparation
Goncalves et al. Chromatographic and immunochemical studies on lysozyme
Aimoto et al. Influence of Anhydrous Hydrogen Fluoride on Hen Egg-White Lysozyme. I. Effects on Native Hen Egg-White Lysozyme
CN110563833A (zh) 一种人血白蛋白标准物质原料的制备方法及其产品和应用

Legal Events

Date Code Title Description
MKEX Expiry